144. Lennox-Gastaut syndrome Clinical trials / Disease details

Clinical trials : 111 / Drugs : 72 - (DrugBank : 14) / Drug target genes : 49 - Drug target pathways : 61

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00518713 (ClinicalTrials.gov)	August 2007	20/8/2007	Clobazam in Patients With Lennox-Gastaut Syndrome	Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam in Patients With Lennox-Gastaut Syndrome	Epilepsy;Epilepsy, Generalized;Seizures	Drug: Clobazam Low Dose;Drug: Clobazam Medium Dose;Drug: Clobazam High Dose;Drug: Placebo	Lundbeck LLC	NULL	Completed	2 Years	60 Years	All	238	Phase 3	United States;Australia;Belarus;India;Lithuania;Serbia
2	NCT00162981 (ClinicalTrials.gov)	October 2005	9/9/2005	Clobazam in Subjects With Lennox-Gastaut Syndrome	Safety and Efficacy of Clobazam in Subjects With Lennox-Gastaut Syndrome	Epilepsy;Epilepsy, Generalized;Seizures	Drug: Clobazam Low Dose;Drug: Clobazam High Dose	Lundbeck LLC	NULL	Completed	2 Years	30 Years	All	68	Phase 2	United States